Tenderwize
Retour à la recherche

Open House Discount Agreements Amifampridin

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jul 03, 2027 · 308 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Amifampridin, ATC N07XX05

40/100

Score d'opportunité

PromisingLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

20 / 100

Facteurs de risque

No guaranteed value; actual revenue depends on market uptake and may be low.

Submission process is specific: use communication area (not offer area) and strictly follow format (electronic qualifie...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Strong opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2027
  • Enter into non-exclusive discount agreements for the pharmaceutical active substance Amifampridin (ATC N07XX05) with AOK Bayern.
  • Agreements are based on a standardized, non-negotiable contract template.
Afficher le résumé complet

This notice describes an open house model (not a competitive procurement) for non-exclusive pharmaceutical discount agreements on the active substance Amifampridin (ATC N07XX05) by AOK Bayern. Any eligible pharmaceutical company can join at any time during the contract term. The agreement period is from 01.09.2025 to 31.08.2027, with contracts possible until 03.07.2027. There is no selection process; all qualifying companies that submit the required documents will be accepted. No estimated value is provided. The tender is open only to pharmaceutical companies, and all documents must be in German.

Risques

No guaranteed value; actual revenue depends on market uptake and may be low.

Submission process is specific: use communication area (not offer area) and strictly follow format (electronic qualifie...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Proof of authorization (commercial register extract or power of attorney) for signatories.

Eligibility

  • Only pharmaceutical companies are eligible to participate.

Administrative

  • Submission of a completed and signed contract, signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and signed declaration of reliability.

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No award criteria - open house model; any qualified company may join.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open House Discount Agreements Amifampridin

Open house model for discount agreements on Amifampridin (ATC N07XX05). Any qualifying pharmaceutical company may join. Contracts start on the first of the month following submission (if submitted by the 3rd). No competitive selection; all eligible participants are accepted. Contract duration 01.09.2025-31.08.2027.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Aug 2025 - Aug 2027

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria - open house model; any qualified company may join.

Date limite

Deadline Jul 03, 2027

Détails de la procédure

Date de publication
13 Jul 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
456857-2025

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30